Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MARA Schedules Conference Call for Third Quarter 2026 Financial Results
-
Zomee Announces Industry-Leading Warranty Protection, Giving Moms More Confidence in Every Pump
-
Brixton Metals Announces Closing of First Tranche of Non-Brokered Private Placement
-
Sinai Health Foundation Puts Chronic Inflammation in the Spotlight
-
Edible Garden CEO Jim Kras to Discuss Innovation and Diversification at 2026 CEAg World Conference & Expo
-
Asure Software and Vertex Announce Strategic Alliance to Expand Payroll Tax Management Reach
-
Humacyte To Announce 2026 Third Quarter Financial Results and Provide Business Update on November 10, 2026
-
Fusemachines Launches New Video Series Showcasing Technology Maturity of HireFoundry.ai's Real-Time Interview Agent
-
New Adyen Data Reveals Canadian Small Businesses Risk Layoffs and Closures as Funding and Cash Flow Gaps Widen, New Adyen Data Shows
-
Radiopharm Theranostics Reports Business Update
-
Season’s Eatings: Tyson® Debuts New Holiday Nuggets
-
Rein Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
-
Edible Garden CEO Jim Kras to Discuss Innovation and Diversification at 2026 CEAg World Conference & Expo
-
Fluence Strengthens Executive Leadership Team to Accelerate Operational Transformation
-
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer
-
NowVertical Announces Resignation of Director
-
Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response
-
New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation
-
Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets
-
Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.
-
CytomX Therapeutics to Present at Upcoming November Investor Conferences
-
New SEON Survey Finds U.S. Consumers Are Embracing AI Agents, but 65% Would Blame the AI Company if One Commits Fraud
-
Rectitude Holdings Ltd. Announces Acquisition of MR. BUTLER PTE. LTD. and Executes Business Migration Agreements with INOS and G & L
-
Syntec Optics (Nasdaq: OPTX) Secures 25% Order Increase for Advanced Space Reconnaissance
-
Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response
-
SEALSQ to Host “Quantum Days” Event in Cannes as Official Sponsor of the First World Quantum Cannes Festival
-
Fusemachines Launches New Video Series Showcasing Technology Maturity of HireFoundry.ai's Real-Time Interview Agent
-
EagleBurgmann To Showcase Dry Gas Seal Solutions for Greater Compressor Reliability and Lower Operating Costs at ADIPEC 2026
-
Stratum Holdings CEO Issues Shareholder Letter Highlighting Progress in AI Infrastructure Transformation
-
Lyell Immunopharma To Participate in November Investor Events
-
Innventure Announces Formation of Strategic Review Committee to Review Range of Capital Strategies
-
Terra Balcanica Spin Off Terra North Resources Identifies Additional Uranium Targets over Fontaine lake, Saskatchewan
-
Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective
-
Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
-
XMax Announces AI Infrastructure Services Agreement, Expects Over US$100 Million in Revenue Over the Next Five Years
-
Former Microsoft and Cisco Security Executive Edna Conway Joins Known Advisory Council
-
Menlo Microsystems Appoints John B. Kennedy as Chief Financial Officer
-
Callan JMB Announces Arrival of Rapid Dose Therapeutics’ QuickStrip™, Resulting in $15 Million in Projected Revenue Over the Next 18 months
-
UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer
-
AMLM Signs Earn-In Agreement to Earn Up to 85% Interest in Yuinmery Gold Project, Positioning Company for Significant Exploration Growth
-
Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China
-
Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
-
Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population
-
The Office Gurus Announces Acquisition of Select VoiceCom, Expanding Global Delivery Capabilities in the Philippines
-
DeFi Development Corp. Surpasses 2.6 Million SOL as CHAD’s 14% Annualized Dividend Rate Takes Effect
-
AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry
-
RANE Partners with ISM to Help Global Supply Chain Professionals Get Ahead of Disruption
-
General Fusion to Host Third Quarter 2026 Results Conference Call
-
HyOrc Reports 75.43% Combined Hydrogen and Carbon Monoxide in RDF-Derived Syngas, with Just 0.76% Nitrogen
-
NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology
